Saphenous veins are commonly used as coronary artery bypass grafts. Therefore, it is important to understand the vein wall morphology used for the bypass grafts.
INTRODUCTION
Th e venous system constitutes an adaptable and variable system from person to person and, as such, has been an oft en-overlooked part of vascular anatomy. Nonetheless, the continued use of veins in operative techniques such as bypasses in addition to highly debilitating manifestations of venous disease stresses the importance of understanding the vein wall and the venous system. In spite of the common basic function of arteries and veins in transporting blood, signifi cant distinctions continue to be found in the organic backgrounds of the two types of vessels.
Th e venous wall is composed of three layers, the intima, the media, and the adventitia. Th e internal elastic layer further separates the intima and the media, and the external elastic layer separates the media and adventitia [1, 2] .
Intima. Th e intima consists of one layer of simple squamous epitheliumendothelium -sitting on an incomplete elastic basement membrane. Under normal healthy conditions, the endothelial cells have essential roles in venous wall integrity and function. Th ese cells produce vasorelaxants, such as prostacyclin (PGI 2) and NO, which are known to prevent platelet activation, adhesion, and aggregation. NO also negatively aff ects the expression of chemical mediator secretion and infl ammatory cell adhesion molecules including intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1). [1, 3, 4] .
In humans, the intima develops only aft er birth and forms completely by 6 months of age. Th ere is no defi nite internal elastic lamina and, as in arteries, the thickness of the intima increases with age (phlebosclerosis). In arteries the earliest signs of atherosclerosis and fatty streaks appear in the areas of sheer stress and increased intimal thickness. [4, 5, 6] .
Media. Th e media is composed of circularly arranged smooth muscle cells and varies greatly according to location. Small veins have only a thin muscular wall, but in larger channels, such as the saphenous vein and the inferior vena cava, there are coarse bundles of irregular muscle, partially organised into longitudinal and circular layers [1, 5, 7] . However, in general, it is less well developed than that of the arterial system. Th is thin media may contribute to the development of varicosities in lower extremity veins. Larger-calibre veins have limited contractile capacity in comparison to the thicker-walled great saphenous vein [1, 5, 8] . Th e smooth muscle cells of this layer are held in a quiescent state in the normal venous environment by various factors. Th e tunica media contains extracellular connective elements (elastin, collagen types I and III, proteoglycans, and glycosaminoglycans) and vascular smooth muscle cells. Transforming growth factor-β downregulates their mitogenesis and stabilizes the extracellular matrix against smooth muscle cell migration. In addition, heparin and heparin-like molecules neutralize the fi broblast growth factor to downregulate cell proliferation. Th is process is important because these factors keep the normal vessel wall in a state of low cell turnover with low rates of proliferation and apoptosis. Injury or changes to the environment, as when veins are exposed to arterial fl ow, can increase the rates of proliferation or apoptosis [1, 9, 10] .
Adventitia. External to a poorly developed external elastic lamina is the adventitia, a loose connection of extracellular matrix with a sparse vasa vasorum. It is generally the thickest layer in large veins. It may sometimes blend with the media. Bundles of longitudinally oriented smooth muscle cells are interspersed with collagen and elastic fi bres in this layer. Adventitia may contain bundles of longitudinally oriented smooth muscle cells interspersed with collagen and elastic fi bres. Th e abundant collagen fi bres have either a longitudinal or helical orientation. Compared with vasa vasorum of the corresponding arteries, vasa vasorum are much more extensive in venous adventitia and penetrate into deeper regions of the adventitia as well. Lower oxygen tension in venous blood is a possible explanation for this phenomenon [1, 3, 10] .
In general, veins have thinner walls than their corresponding arteries because their cellular and fi brous components are typically more limited than those of the arterial system. Th e relevance of the diff erence in the media+adventitia thickness is unknown. It should be noted that the composition of vein walls is also diff erent, with a relative abundance of collagen fi bres, particularly in large veins, and a relative paucity of elastic fi bres -as might be assumed from the diminished internal and external elastic laminae. Researchers increasingly have recognized the vein graft tunica adventitia as an important repository of progenitor cells which subsequently can migrate and proliferate; and as a source of vascular wall infl ammatory cells, cytokines, and chemokines. [1, 11, 12, 13] .
Specific factors of the vein wall
Endothelin-1 (ET-1) is the most abundant and important endothelin produced by endothelial cells. ET-1 carries out its eff ects through two types of membrane-G protein-coupled receptors, ET A and ET B. Many important functions are mediated by the activation of these receptors, such as cardiovascular remodelling, vasoconstriction, cell proliferation and diff erentiation, production of extracellular matrix, and water and sodium secretion control. ET receptors can be found on vascular smooth muscle cells, adventitial fi broblasts, and endothelial cells. [14, 15, 16] .
Matrix metalloproteinases (MMPs), also called matrixins, function in the extracellular environment of cells and degrade both matrix and non-matrix proteins. Matrix metalloproteinases are produced by smooth muscle cells and macrophages to actively modify the matrix. Th ey play central roles in morphogenesis, wound healing, tissue repair and remodelling in response to injury. Th ey are multi-domain proteins and their activities are regulated by tissue inhibitors of metalloproteinases (TIMPs). In addition to an inhibitory role against metalloproteinases, the encoded protein has a unique role among TIMP family members in its ability to directly suppress the proliferation of endothelial cells. As a result, the encoded protein may be critical to the maintenance of tissue homeostasis by suppressing the proliferation of quiescent tissues in response to angiogenic factors, and by inhibiting protease activity in tissues undergoing remodelling of the extracellular matrix [16, 17, 18] .
Transforming growth factor beta (TGFβ) encoded protein regulates cell proliferation, diff erentiation and growth, and can modulate expression and activation of other growth factors. TGFβ critically regulates the development of neointima formation following vascular injury; however, the underlying signalling mechanisms remain to be fully elucidated. Two distinct type I TGF-β receptors, Alk-1 and Alk-5, are both expressed in endothelial cells and pericytes [17, 18, 19] .
Hepatocyte growth factor (HGF) binds to the hepatocyte growth factor receptor to regulate cell growth, cell motility and morphogenesis in numerous cell and tissue types. It also plays a role in angiogenesis, tumorogenesis, and tissue regeneration. Pleiotropic growth factor has potential angiogenic, anti-apoptotic, antifi brotic and anti-infl ammatory benefi ts [17, 20] .
Vascular endothelial growth factor (VEGF) induces proliferation and migration of vascular endothelial cells and is essential for both physiological and pathological angiogenesis. Furthermore, stretch-induced modulation of genes involved in myogenic diff erentiation (VEGF) contributes to the vascular remodelling that underlies pathologic complications, such as neointima development and atherosclerosis of the vein graft s. [7, 17, 21] .
Protein Gene Product 9.5 (PGP 9.5) is also known as ubiquitin C-terminal hydrolase 1 (UCHL-1). Expression of PGP9.5 is highly specifi c to neurons and to cells of the diff use neuroendocrine system. Originally isolated as a neuronspecifi c protein, it also plays important roles in the nonlysosomal proteolytic pathway [22, 23] .
Vascular cell adhesion molecule 1 (VCAM-1) encodes a cell surface sialoglycoprotein expressed by cytokine-activated endothelium. Th is type I membrane protein mediates leukocyte-endothelial cell adhesion and signal transduction and may play a role in the development of atherosclerosis. VCAM-1 expression has been detected on cell types other than endothelium, including macrophages, dendritic cells, astrocytes, bone marrow stromal cells, and respiratory epithelial cell lines [17, 24] .
Intercellular adhesion molecule 1 (ICAM-1) is a member of the immunoglobulin superfamily of adhesion receptors and is associated with several common diseases, such as heart disease and stroke. It is a cell surface glycoprotein which is typically expressed on endothelial cells and cells of the immune system and is involved in the binding of a cell to another cell or to the extracellular matrix. Levels of endothelial ICAM-1 expression greatly increase aft er stimulation by cytokines (e.g., IL-1, TNF-α, IFN-γ) or bacterial endotoxin. Th ey have roles in cell proliferation, diff erentiation, motility, traffi cking, apoptosis and tissue architecture [17, 24, 25] .
Aim of the study
Th e aim of this study was to evaluate morphologic features of healthy saphenous vein used in coronary artery bypass surgery.
MATERIAL AND METHODS
Vein samples were acquired at the Heart Surgery Centre of Pauls Stradiņš Clinical University Hospital from patients who were admitted to the hospital for coronary artery bypass surgery. Th e patients' records were retrieved and analysed according to a predetermined protocol.
Ten specimens of saphenous veins were obtained from 10 patients (7 males and 3 females) whose age ranged from 55 to 81 years. Th ey had been admitted to the Heart Surgery Centre of Pauls Stradiņš Clinical University Hospital for coronary artery bypass surgery, and a histopathological study was conducted.
Th e research was approved by the hospital's Ethics Committee and local Committee of Ethics at Riga Stradiņš University on 22 February 2018. All patients were informed about the procedure and the handling of the received samples.
Data on vascular risk factors were collected from all patients during their visits.
Methods
Two-to three-centimetre-long tissue fragments were taken from operation material using the less traumatic technique.
Th e tissue fragments were fi xed for 24 hours in Stefanini solution -a mixture consisting of 2% formaldehyde and 0.2% picric acid in 0.1-M phosphate buff er (pH 7.2) (Stefanini et al., 1967) and were subsequently washed for 12 hours in phosphate buff er (pH 7). Th en, tissues were embedded in paraffi n and 3-4 μm thick sections were prepared by microtome. Th e tissue deparaffi nization was carried out with xylene, and the tissue was then dehydrated with alcohol 96º. Th e slides were processed for histological routine straining to obtain an overview picture as well as immunohistochemical staining using the HiDef detection method to identify the following markers in tissue samples: endotelin (mouse, ab-2786, 1:250, Abcam), metalomembranoproteinase 2 (MMP2) (mouse, sc-53630, 1:100, Santa Cruz Biotechnology, Inc), tissue inhibitor of metalloproteinase 2 (TIMP2) (mouse, sc-21735, 1:200, Santa Cruz Biotechnology, Inc), transforming growth factor beta (TGF β) (rabbit, sc-82, 1:100, Santa Cruz Biotechnology, Inc), hepatocyte growth factor (HGF) (goat, f-21, 1:300, RD Systems), vascular endothelial growth factor (VEGF) (rabbit, orv-191500, 1:100, Biorbyt), protein gene product 9.5 (PGP9.5) (rabbit, 439273a, 1:200, Initrogen), vascular cell adhesion molecule (VCAM) (goat, cd-106, 1:200, RD Systems), intercellular adhesion molecule (ICAM) (goat, cd-54, 1:300, RD Systems).
Tissue samples were rinsed with TRIS buff er (Lot 0713513, Diapath S.p.A., Italy) twice for 5 minutes, and placed in boiling EDTA buff er (Lot 0713311, Diapath S.p.A., Italy) in a microwave oven for up to 20 minutes. Th e container with the samples was then cooled in the buff er for up to 20 minutes, until it reached 65 º C. Th e specimen was placed in a TRIS wash buff er, and blocking with peroxidase block (Lot 1213603A, Cell Marque, USA) was performed for 10 minutes. Th e next steps were rinsing twice for 5 minutes as well as rinsing in TRIS wash buff er for 5 minutes.
For antibodies obtained from goat, the LSAB staining system (Santa Cruz Biotechnology, Inc., USA) was used. First, incubation with the primary antibody for 2 hours was performed, followed by washing in TRIS wash buff er for 5 minutes and then incubation for 30 minutes with biotin (secondary antibody). Th is process was followed by washing in TRIS buff er for 5 minutes, incubation for 30 minutes with the HRP-streptavidin complex, and then washing in TRIS wash buff er again for 5 minutes. Tissue coating with the liquid DAB+ chromogenic substrate system as well as incubation at room temperature, which together resulted in a positive structure being coloured brown, was carried out for up to 10 minutes. Th e sample was then washed in distilled water for 5 minutes and counterstained with haematoxylin (Mayer`s haematoxylin, Bio Optica Milano S.p.A., Italy) for 2 minutes.
For antibodies obtained from mouse or rabbit, the EnVision staining system (Lot 1528902C, Cell Marque, USA) was used. Incubation with the primary antibody for 1 hour was followed by washing in TRIS washing buff er twice for 5 minutes and the En Vision+/binding phase for 30 minutes. Washing in TRIS washing buff er twice was then repeated. Tissue coating with liquid DAB+ substrate chromogenic system and incubation at room temperature was performed, resulting in a positive structure having brown coloration; this took between 1-10 minutes, aft er which the sample was washed in distilled water for 5 minutes and counterstained with haematoxylin (Mayer`s haematoxylin, Bio Optica Milano S.p.A., Italy) for 2 minutes.
For the analysis of the positive structures detected by immunohistochemistry, a semiquantitative evaluation method was used (Pilmane et al., 2011). Th e designations were as follows: 0 -negative reaction; 0/+ -occasionally marked structures in the view fi eld; + -a few positive structures in the view fi eld; +/++ -a few to moderate number of positive structures in the view fi eld; ++ -a moderate number of positive structures found in the view fi eld; ++/+++ -moderate to numerous positive structures; +++ -numerous positive structures in the view fi eld; ++++ -abundance of positive structures in view fi eld. Th e evaluation was performed with a Leica microscope.
RESULTS
Vein sections revealed normal histoarchitecture of the vein wall composed of 3 tunicae evaluated in routine staining (Fig.1) . Th e fi rst tunica from the luminal side was the intima, which was fully or partially covered with endothelial cells. Tunica intima in all specimens was thin with one exception, where tunica intima was thick, wider than tunica media (Fig.2) . Th e media was thick and fi lled with smooth muscle cells with one exception where the tunica media was thin. Th e tunica adventitia consisted of bundles of collagen fi bres, fi broblasts, vasa vasorum, a few of which were sclerotic in all specimens.
Immunohistochemistry results Moderate (++) positive endothelin containing endothelial cells (Fig. 3) as well as moderate to numerous (++/+++) positive VEGF endothelial cells were found on small blood vessels. Moderate (++) positive MMP2 endothelial cells, smooth muscle cells and fi broblasts (Fig.4) and variable -mainly moderate to numerous (++/+++) positive TIMP endothelial cells, smooth muscle cells and fi broblasts were found. Despite variability, in all cases positive structures were evaluated as equal with both MMP2 and TIMP with one exception where MMP2 positive structures were evaluated as moderate (++), but TIMP positive structures were evaluated as few (+). All specimens were rich in TGFβ, VCAM and ICAM, numerous (+++) TGFβ structures. Abundance (++++) of VCAM and ICAM positive endothelial cells was also found. HGF expression was not characteristic in veins and only few (+) positive structures were found in tunica intima. Few (+) PGP9,5 positive nerve fi bres were found in tunica adventitia. 
DISCUSSION
Moderate endothelin and moderate to numerous VEGF endothelial cells found by us in v.saphena magna wall is characteristic of healthy veins. VEGF is a secreted protein; its binding sites are selectively expressed in endothelial cells in vitro and in vivo; the expression of its mRNA is correlated to blood vessel growth [26] . Endothelin, on the other hand, is considered an important mediator in vessel remodelling, ultimately leading to major changes in cellular and tissue architecture [21] .
Equal number of positive MMP2 and TIMP2 endothelial cells, smooth muscle cells and fi broblasts detected in saphenous vein suggests the balance between tissue degeneration enzymes and their inhibitors, while any exception to this model might be a deviation from the ontogenetic norm and plays an important role in vein bypass graft functionality. Mid-term and late saphenous vein graft failure is determined by formation of the neointima [27] . Although, many local and systemic factors have an impact on its development, this process always involves smooth muscle cells located in the tunica media of the saphenous vein segment [28] . Smooth muscle cells release matrix metalloproteinases (MMPs) that degrade extracellular matrix [29] . Th ey also produce tissue inhibitors of metalloproteinases (TIMPs), and a balance between MMPs and TIMPs eventually determines the local homeostasis of the extracellular matrix [30] . In research by Perek et al. (2016) evaluating the expression of proteins, the majority of saphenous vein segments exhibited weak or moderate immunostaining of MMP-2, TIMP-2 and TIMP-3 within the tunica media. Th e tissue expression of MMP-2 and TIMPs has been associated with the age of the patients [31] . Th e degradation of extracellular matrix by MMPs, which provides a structural framework essential for the functional properties of vessel wall, was found to be a prerequisite for smooth muscle cells migration, a critical step in neointima formation [27] . Moreover, baseline level of MMP-2 in the saphenous vein wall was shown to have a strong linear correlation with the degree of luminal narrowing at 1 year aft er coronary artery bypass graft [32] . Perek et al. (2016) stated that saphenous vein segments may be more appropriate graft s in the elderly population. Moreover, their study also demonstrated increased tissue activity of TIMP-2 and TIMP-3 in the tunica media of the saphenous vein segments [31] . However, no correlation between the age of the patient and TIMP-2 activity in the human aortic specimen had been demonstrated [33] . Th erefore, it has been suggested that TIMP-3 is a senescence-related protein [34] . Heavy smoking also noticeably increases native MMP2 and MMP9 gene expression in the saphenous vein before coronary artery bypass graft . Even aft er long-term cessation of smoking, the dysregulated MMP2 and MMP9 gene expression cannot recover to normal levels. With the elevated native MMP2 and MMP9 gene expression in the saphenous vein induced by heavy smoking, more vein graft disease can be found on long-term follow-up [35] .
HGF is not a signifi cant factor in the v.saphena magna wall, because as Gallo et al. (2015) stated, the HGF and its receptor Met pathway has a prominent role in cardiovascular remodelling aft er tissue injury [36] . However, the abundant deposits of TGFβ, VCAM and ICAM are important for the maintenance of large vein homeostasis. George et al. (2005) suggest that the amount of TGFβ in human saphenous vein is suffi cient, when in the active form, to protect smooth muscle cells against apoptosis. Decreasing the amount of active TGFβ causes smooth muscle cells to undergo apoptosis, but adding exogenous TGFβ has no benefi cial eff ect [37] , while gene expression of MMP9, MMP12, TIMP1 and TIMP2 is infl uenced by the addition of TGF-β1. Th ese results may be translated to chronic venous insuffi ciency framework and suggest involvement of TGF-β1 in the vein wall pathology [38] .
Saphenous veins used as coronary artery bypass graft s have a specifi c distribution of the expression of the adhesion molecules ICAM-1 and VCAM-1. Th ese molecules, which belong to the immunoglobulin superfamily, mediate adhesion and transmigration of blood leukocytes through the endothelium. Th e adhesion of all leukocytes is mediated by the expression of ICAM-1, whereas VCAM-1 is specifi c for lymphocytes, monocytes, and eosinophils. Adhesion of blood elements to the endothelium is an important step in the development of vein graft disease [39] . Th e endothelium is immunoregulatory in that inhibiting the function of vascular adhesion molecules blocks leukocyte recruitment and, thus, tissue infl ammation. Endothelium is stimulated to express adhesion molecules that mediate leukocyte binding. Upon leukocyte binding, these adhesion molecules activate endothelial cell signal transduction that then alters endothelial cell shape for the opening of passageways through which leukocytes can migrate. If the stimulation of this opening is blocked, infl ammation is blocked. VCAM-1 on the endothelium functions as both a scaff old for leukocyte migration and a trigger of endothelial signalling [40] .
V. saphena magna is not richly innervated with neuropeptide-containing nerve fi bres. Gulbenkian et al. (1987) discovered that, in the vascular system of guinea pigs, PGP 9.5 immunoreactivity occurred in an extensive plexus of fi ne perivascular nerve fi bres and fascicles running around and along both arteries and veins, mainly at the adventitial-medial border [41] . Th is shows that only the fascicles of nerve fi bres enter the wall of the vein.
CONCLUSIONS
V. saphena magna used for coronary artery bypass surgery possess a moderate number of VEGF and MMP positive cells with slightly more TIMP immunoreactive cells suggesting the connective tissue remodellation and presence of tissue ischemia. Healthy v. saphena magna is characterised by rich expression of TGFβ, VCAM and ICAM structures. HGF seems not to be involved in homeostasis regulation of these blood vessels which are slightly innervated by neuropeptide containing nerves.
